Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CEO Jodie Pope Morrison Sells 3,221 Shares of Stock

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CEO Jodie Pope Morrison sold 3,221 shares of the stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $8.32, for a total value of $26,798.72. Following the completion of the transaction, the chief executive officer directly owned 340,038 shares in the company, valued at approximately $2,829,116.16. This trade represents a 0.94% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jodie Pope Morrison also recently made the following trade(s):

• On Tuesday, August 25th, Jodie Pope Morrison sold 9,845 shares of Leverage Shares 2X Long FIX Daily ETF stock. The stock was sold at an average price of $16.56, for a total value of $163,033.20.

Leverage Shares 2X Long FIX Daily ETF Price Performance

Shares of Leverage Shares 2X Long FIX Daily ETF stock opened at $11.01 on Thursday. Leverage Shares 2X Long FIX Daily ETF has a 12 month low of $11.00 and a 12 month high of $15.92.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.